NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Novo Nordisk A/S (CO: NOVO-B)

 
NOVO-B Technical Analysis
5
As on 17th Feb 2026 NOVO-B STOCK Price closed @ 309.90 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 479.44 & Strong Sell for SHORT-TERM with Stoploss of 652.91 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NOVO-BSTOCK Price

Open 307.75 Change Price %
High 311.55 1 Day 2.25 0.73
Low 307.60 1 Week 14.40 4.87
Close 309.90 1 Month -54.15 -14.87
Volume 3434406 1 Year -437.70 -58.55
52 Week High 790.30 | 52 Week Low 280.65
 
CO Denmark Most Active Stocks
SAS 0.01 0.00%
NOVO-B 309.90 0.73%
CONFRZ 0.02 0.00%
VJBA 7.33 0.41%
VWS 157.35 0.90%
ALMB 16.53 0.79%
ORSTED 152.45 -0.59%
SHAPE 5.03 30.65%
GREENH 0.41 -6.82%
ASTRLS 1.15 8.49%
 
CO Denmark Top Gainers Stocks
LEDIBOND 0.03 50.00%
HYDRCT 0.60 46.34%
SHAPE 5.03 30.65%
HYPE 3.66 22.00%
MDUNDO 3.50 20.69%
DKIEEU 249.00 15.81%
SAME 1.45 10.69%
SAME 1.45 10.69%
ASTRLS 1.15 8.49%
ATLA-DKK 2.47 7.39%
 
CO Denmark Top Losers Stocks
VALUER 0.25 -21.88%
BLVIS-A 0.40 -18.37%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
 
 
NOVO-B
Daily Charts
NOVO-B
Intraday Charts
Whats New @
Bazaartrend
NOVO-B
Free Analysis
 
NOVO-B Important Levels Intraday
RESISTANCE317.51
RESISTANCE315.07
RESISTANCE313.56
RESISTANCE312.05
SUPPORT307.75
SUPPORT306.24
SUPPORT304.73
SUPPORT302.29
 
NOVO-B Forecast February 2026
4th UP Forecast527.46
3rd UP Forecast457.69
2nd UP Forecast414.56
1st UP Forecast371.43
1st DOWN Forecast248.37
2nd DOWN Forecast205.24
3rd DOWN Forecast162.11
4th DOWN Forecast92.34
 
NOVO-B Weekly Forecast
4th UP Forecast381.20
3rd UP Forecast358.33
2nd UP Forecast344.20
1st UP Forecast330.07
1st DOWN Forecast289.74
2nd DOWN Forecast275.60
3rd DOWN Forecast261.47
4th DOWN Forecast238.60
 
NOVO-B Forecast2026
4th UP Forecast1333.52
3rd UP Forecast1005.24
2nd UP Forecast802.32
1st UP Forecast599.4
1st DOWN Forecast20.4
2nd DOWN Forecast-182.52
3rd DOWN Forecast-385.44
4th DOWN Forecast-713.72
 
 
NOVO-B Other Details
Segment EQ
Market Capital 1565371138048.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NOVO-B Address
NOVO-B
 
NOVO-B Latest News
 
Your Comments and Response on Novo Nordisk A/S
 
NOVO-B Business Profile
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Allé 1, Bagsvaerd, Denmark, 2880
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service